Salarius Pharmaceuticals Inc(SLRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SLRX Salarius Pharmaceuticals Inc

Trading 11-25 13:56:09 EST

1.57

+0.20

+14.60%

High1.57	Low1.37	Vol34.78K
Open1.37	D1 Closing1.37	Amplitude14.60%
Mkt Cap2.26M	Tradable Cap2.21M	Total Shares1.44M
T/O50.77K	T/O Rate2.48%	Tradable Shares1.40M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"SLRX","market":"US","secType":"STK","nameCN":"Salarius Pharmaceuticals Inc","latestPrice":1.57,"timestamp":1732560896469,"preClose":1.37,"halted":0,"volume":34779,"delay":0,"floatShares":1404878,"shares":1441157,"eps":-6.893912,"marketStatus":"Trading","change":0.2,"latestTime":"11-25 13:56:09 EST","open":1.37,"high":1.57,"low":1.37,"amount":50772.9265449,"amplitude":0.145985,"askPrice":1.57,"askSize":19,"bidPrice":1.52,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-6.893912,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1732568400000},"marketStatusCode":2,"adr":0,"listingDate":1422507600000,"exchange":"NASDAQ","adjPreClose":1.37,"preHourTrading":{"tag":"盘前","latestPrice":1.3686,"preClose":1.37,"latestTime":"09:21 EST","volume":25,"amount":34.215,"timestamp":1732544504980},"postHourTrading":{"tag":"盘后","latestPrice":1.37,"preClose":1.37,"latestTime":"16:30 EST","volume":20,"amount":28.6,"timestamp":1732311020988},"volumeRatio":1.493148},"requestUrl":"/m/hq/s/SLRX","defaultTab":"news","newsList":[{"id":"2483371843","title":"Salarius Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2483371843","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483371843?lang=en_us&edition=fundamental","pubTime":"2024-11-15 22:04","pubTimestamp":1731679484,"startTime":"0","endTime":"0","summary":"* Salarius Pharmaceuticals Inc    reported a quarterly adjusted loss of 76 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Salarius Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLRX"],"gpt_icon":0},{"id":"2483368016","title":"Salarius: Q3 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2483368016","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483368016?lang=en_us&edition=fundamental","pubTime":"2024-11-15 08:25","pubTimestamp":1731630328,"startTime":"0","endTime":"0","summary":"HOUSTON  — HOUSTON  — Salarius Pharmaceuticals, Inc.  on Thursday reported a loss of $972,000 in its third quarter.The Houston-based company said it had a loss of 76 cents per share.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/salarius-q3-earnings-snapshot-002528075.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SLRX"],"gpt_icon":0},{"id":"2458542437","title":"Salarius: Q2 Earnings Snapshot","url":"https://stock-news.laohu8.com/highlight/detail?id=2458542437","media":"Associated Press Finance","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2458542437?lang=en_us&edition=fundamental","pubTime":"2024-08-10 05:21","pubTimestamp":1723238496,"startTime":"0","endTime":"0","summary":"HOUSTON  — HOUSTON  — Salarius Pharmaceuticals, Inc.  on Friday reported a loss of $1.4 million in its second quarter.On a per-share basis, the Houston-based company said it had a loss of $2.37.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/salarius-q2-earnings-snapshot-212136692.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SLRX"],"gpt_icon":1},{"id":"2454087743","title":"Dow Jumps 200 Points; Honeywell Trims Profit Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2454087743","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2454087743?lang=en_us&edition=fundamental","pubTime":"2024-07-25 22:39","pubTimestamp":1721918389,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/07/39961101/dow-jumps-200-points-honeywell-trims-profit-outlook","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","EZFL","KDLY","MNQmain","QID","TQQQ","PCOM","PBM","BK4122","BK4550","BK4196","TWOU","PSQ","BK4204","BK4082","HON","NQmain","LU0683600562.USD","QLD","IE00B1BXHZ80.USD","LU0787776722.HKD","SLRX","POAI","SQQQ","BK4139","BK4585","BK4206","BK4588","IE0034235188.USD",".IXIC","BK4534","BK4144"],"gpt_icon":1},{"id":"2452284377","title":"BUZZ-Salarius Pharma falls on ending early-stage bone cancer study","url":"https://stock-news.laohu8.com/highlight/detail?id=2452284377","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2452284377?lang=en_us&edition=fundamental","pubTime":"2024-07-20 05:46","pubTimestamp":1721425583,"startTime":"0","endTime":"0","summary":"** Shares of drug developer Salarius Pharmaceuticals  fall 4.4% to $1.75 after the bell     ** Co to close its ongoing early-stage trial testing its experimental drug seclidemstat in patients with a type of bone cancer   ** Co says it is ending the study in an effort to conserve cash while its board of directors continues its exploration of potential strategic alternatives   ** The US FDA placed a partial clinical hold on another cancer study testing seclidemstat in patients with a type of blood cancer on July 11    ** Up to last close, stock down 64.8% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","BK4139","SLRX"],"gpt_icon":1},{"id":"2452871281","title":"BRIEF-Salarius Pharmaceuticals Says Now Determined To Close Ongoing Phase 1/2 Clinical Trial Evaluating Seclidemstat For Ewing Sarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2452871281","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2452871281?lang=en_us&edition=fundamental","pubTime":"2024-07-20 05:20","pubTimestamp":1721424006,"startTime":"0","endTime":"0","summary":"July 19  - Salarius Pharmaceuticals Inc :   * SALARIUS PHARMACEUTICALS INC: NOW DETERMINED TO CLOSE ONGOING PHASE 1/2 CLINICAL TRIAL EVALUATING SECLIDEMSTAT FOR EWING SARCOMA   * SALARIUS PHARMACEUTICALS INC - TERMINATING THE ONGOING CLINICAL TRIAL IN AN EFFORT TO CONSERVE CASH   * SALARIUS PHARMACEUTICALS INC: CONTINUES ITS EXPLORATION OF POTENTIAL STRATEGIC ALTERNATIVES   * SALARIUS PHARMACEUTICALS: TO CONTINUE SUPPORT FOR MDACC'S SPONSORED CLINICAL TRIAL EVALUATING SECLIDEMSTAT  IN COMBINATION WITH AZACITIDINESource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLRX","BK4139"],"gpt_icon":0},{"id":"2452890682","title":"SALARIUS PHARMACEUTICALS INC: NOW DETERMINED TO CLOSE ONGOING PHASE 1/2 CLINICAL TRIAL EVALUATING SECLIDEMSTAT FOR EWING SARCOMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2452890682","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2452890682?lang=en_us&edition=fundamental","pubTime":"2024-07-20 05:15","pubTimestamp":1721423714,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240719:nFWN3JB1AK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2023250504.SGD","LU0943347566.SGD","LU1153585028.USD","LU1989764664.SGD","LU1923622614.USD","LU2264538146.SGD","BK4566","BK4024","LU0316494557.USD","LU0820561909.HKD","LU2106854487.HKD","LU2125909247.SGD","LU2433249047.HKD","LU2023250843.SGD","NOW","LU2063271972.USD","LU2286300806.USD","LU1551013342.USD","BK4581","LU1951200564.SGD","SLRX","BK4550","LU1917777945.USD","LU0320765059.SGD","LU1064131342.USD","LU0354030438.USD","BK4585","FOR","LU1923623000.USD","LU0708995401.HKD","LU0011850046.USD","LU0109391861.USD","LU1988902786.USD","LU1323610961.USD","IE00BMPRXN33.USD","LU1951198990.SGD","BK4534","LU2458330243.SGD","LU0109392836.USD","LU0672654240.SGD","LU1923622291.USD","LU2458330169.SGD","LU1803068979.SGD","LU2125909593.SGD","BK4097","LU0689472784.USD","BK4528","INC","LU0820561818.USD","IE00BMPRXR70.SGD"],"gpt_icon":0},{"id":"2452628906","title":"SALARIUS PHARMACEUTICALS INC: CONTINUES ITS EXPLORATION OF POTENTIAL STRATEGIC ALTERNATIVES","url":"https://stock-news.laohu8.com/highlight/detail?id=2452628906","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2452628906?lang=en_us&edition=fundamental","pubTime":"2024-07-20 05:15","pubTimestamp":1721423714,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240719:nFWN3JB1AK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLRX","BK4139","INC"],"gpt_icon":0},{"id":"2452289061","title":"SALARIUS PHARMACEUTICALS INC - TERMINATING THE ONGOING CLINICAL TRIAL IN AN EFFORT TO CONSERVE CASH","url":"https://stock-news.laohu8.com/highlight/detail?id=2452289061","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2452289061?lang=en_us&edition=fundamental","pubTime":"2024-07-20 05:15","pubTimestamp":1721423714,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240719:nFWN3JB1AK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SLRX","BK4139","BK4211","INC","CASH"],"gpt_icon":0},{"id":"2452281813","title":"SALARIUS PHARMACEUTICALS: TO CONTINUE SUPPORT FOR MDACC'S SPONSORED CLINICAL TRIAL EVALUATING SECLIDEMSTAT (SP-2577) IN COMBINATION WITH AZACITIDINE","url":"https://stock-news.laohu8.com/highlight/detail?id=2452281813","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2452281813?lang=en_us&edition=fundamental","pubTime":"2024-07-20 05:15","pubTimestamp":1721423714,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240719:nFWN3JB1AK:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4120","BK4139","SP","FOR","SLRX","BK4024"],"gpt_icon":0},{"id":"2450546390","title":"Sector Update: Health Care Stocks Rise Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2450546390","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450546390?lang=en_us&edition=fundamental","pubTime":"2024-07-12 03:51","pubTimestamp":1720727493,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4588","BK4568","PFE.AU","BK4139","LU0289739699.SGD","LU0868494617.USD","LU0321505868.SGD","LU1894683348.USD","SG9999001176.SGD","LU1057294990.SGD","BDRX","LU0456855351.SGD","BK4533","FDN","LU0170899867.USD","LU1894683264.USD","LU1023059063.AUD","SG9999013999.USD","LU0321505439.SGD","PFE","LU1066053197.SGD","BK4592","BK4137","IE00B19Z3B42.SGD","SGXZ57979304.SGD","LU0058720904.USD","LU1883839398.USD","HCSG","NYSE","IE00B19Z3581.USD","SG9999002224.SGD","BK7095","XLV","CFA.SI","BK4534","IE0002270589.USD","BK4585","LU1066051498.USD","SG9999002232.USD","BK4195","SG9999001176.USD","SG9999003800.SGD","BK4196","LU0122379950.USD","HBCP","IE00BLSP4239.USD","PNTG","IBB","IE00BBT3K403.USD","SLRX"],"gpt_icon":0},{"id":"2450106315","title":"Sector Update: Health Care Stocks Rise Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2450106315","media":"MT Newswires","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450106315?lang=en_us&edition=fundamental","pubTime":"2024-07-12 03:51","pubTimestamp":1720727493,"startTime":"0","endTime":"0","summary":"Health care stocks rose late Thursday afternoon with the NYSE Health Care Index adding 0.3% and the Health Care Select Sector SPDR Fund  up 0.7%.In corporate news, Biodexa Pharmaceuticals  shares soared 46% after the company said 12-month data from a mid-stage clinical trial showed the longevity of effect of eRapa in the treatment of precancerous polyps in the gastrointestinal tract.Pennant  shares popped 4.6% after it said Thursday it has signed asset purchase deals to buy assets of some affiliates of Signature Healthcare at Home for $80 million.Salarius Pharmaceuticals  shares sank nearly 13% after it said Thursday the US Food and Drug Administration has placed a trial assessing seclidemstat plus azacitidine in adults with myelodysplastic syndromes and chronic myelomonocytic leukemia on partial clinical hold.Pfizer  shares added 1.2% as it said Thursday it will conduct dose-optimization studies of danuglipron in H2 after selecting a once-daily, modified-release formulation of the dru","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sector-health-care-stocks-rise-195133971.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BDRX","PNTG","IE00BLSP4239.USD","IE0002270589.USD","BK4592","IBB","BK4007","SG9999003800.SGD","LU0058720904.USD","LU0321505439.SGD","SG9999011175.SGD","BK4568","LU0456855351.SGD","LU0122379950.USD","LU1894683264.USD","SG9999002224.SGD","BK4550","BK4196","BK4185","LU1066053197.SGD","SG9999002232.USD","LU1894683348.USD","BK4581","SG9999001176.SGD","LU0289739699.SGD","IE00BLSP4452.SGD","LU1057294990.SGD","LU0234572021.USD","LU0170899867.USD","SG9999013999.USD","XLV","IE00B19Z3581.USD","SLRX","SGXZ57979304.SGD","IE00BBT3K403.USD","LU1883839398.USD","BK4139","BK4585","BK4533","BK4588","LU0868494617.USD","PFE","IE00B19Z3B42.SGD","SG9999001176.USD","BK4534","LU1023059063.AUD","LU1066051498.USD","LU0321505868.SGD"],"gpt_icon":1},{"id":"2450839992","title":"Sector Update: Health Care Stocks Advance in Afternoon Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2450839992","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450839992?lang=en_us&edition=fundamental","pubTime":"2024-07-12 01:51","pubTimestamp":1720720274,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK4550","BK7095","SG9999001176.SGD","LU1066053197.SGD","IE00BLSP4452.SGD","LU1894683348.USD","BK4568","LU0170899867.USD","FDN","BK4581","BK4585","LU0321505439.SGD","LU0868494617.USD","BK4198","IE00BBT3K403.USD","LU0289739699.SGD","LU0321505868.SGD","SLRX","SG9999002224.SGD","BK4588","LU0234572021.USD","SG9999003800.SGD","LU0122379950.USD","LU1057294990.SGD","IBB","IE00B19Z3B42.SGD","IE0002270589.USD","XLV","BK4592","LU1894683264.USD","LU1883839398.USD","BK4139","BK4007","PFE","LU0456855351.SGD","SG9999013999.USD","LU0058720904.USD","LU1066051498.USD","IE00BLSP4239.USD","NYSE","BK4534","PFE.AU","SG9999002232.USD","LU1023059063.AUD","SGXZ57979304.SGD","SG9999001176.USD","SG9999011175.SGD","LNTH","BK4533","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2450999263","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2450999263","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450999263?lang=en_us&edition=fundamental","pubTime":"2024-07-12 01:50","pubTimestamp":1720720240,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["COST","LU0471298694.HKD","BK7095","LU2237438978.USD","IE00BFMHRM44.USD","LU1551013425.SGD","LU0417517546.SGD","LU2125154778.USD","IE00BKVL7J92.USD","LU1323610961.USD","IE0008368304.USD","IE00BZ1G4Q59.USD","BK4155","LU0820561909.HKD","BK4500","LU0234572021.USD","LU2095319765.USD","BK4008","LU1571399168.USD","LU1069344957.HKD","LU1551013342.USD","LU2125154935.USD","BK4588","SLRX","DAL","BK4139","LU0256863811.USD","LU0128525689.USD","IE00B5TLWC47.USD","LU0079474960.USD","LU0820561818.USD","LU0689472784.USD","LU2210150020.SGD","LU0385154629.USD","DAL.AU","LU0234570918.USD","LU2360032135.SGD","LU1496350171.SGD","LU1066053197.SGD","LU0310800965.SGD","BK4550","BK4585","LU0943347566.SGD","LU1066051498.USD","BK4504","LU0052756011.USD","LU1035775433.USD","BK4581","LU2210149790.SGD","LU1267930227.SGD"],"gpt_icon":0},{"id":"2450967513","title":"Sector Update: Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2450967513","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450967513?lang=en_us&edition=fundamental","pubTime":"2024-07-12 01:36","pubTimestamp":1720719409,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["XLV","NYSE","SLRX","BK4139","FDN","BK4585","BK4581","BK4588","IBB"],"gpt_icon":0},{"id":"2450398830","title":"Salarius Pharmaceuticals Says FDA Placed Cancer Treatment Trial on Partial Hold; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2450398830","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450398830?lang=en_us&edition=fundamental","pubTime":"2024-07-12 00:08","pubTimestamp":1720714083,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["MD","BK4139","SLRX","BK4196"],"gpt_icon":0},{"id":"2450398818","title":"Salarius Pharmaceuticals Says FDA Placed Cancer Treatment Trial on Partial Hold; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2450398818","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450398818?lang=en_us&edition=fundamental","pubTime":"2024-07-12 00:08","pubTimestamp":1720714083,"startTime":"0","endTime":"0","summary":"Salarius Pharmaceuticals  said Thursday the US Food and Drug Administration has placed a trial evaluating seclidemstat in combination with azacitidine in adult patients with myelodysplastic syndromes and chronic myelomonocytic leukemia on partial clinical hold.This comes after a patient in the University of Texas MD Anderson Cancer Center's sponsored clinical trial experienced \"a serious and unexpected\" grade-4 adverse event, according to a filing with the US Securities and Exchange Commission.Under the hold, no new patients may be enrolled, though already enrolled subjects may continue treatment and all study procedures if they are benefiting, Salarius said.The company's shares were down about 22% in recent trading.Price: 2.12, Change: -0.59, Percent Change: -21.77","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","SLRX"],"gpt_icon":1},{"id":"2450235028","title":"Salarius Pharmaceuticals Shares Fall 11.7% as FDA Puts Cancer Drug Trial on Partial Clinical Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2450235028","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450235028?lang=en_us&edition=fundamental","pubTime":"2024-07-11 21:32","pubTimestamp":1720704750,"startTime":"0","endTime":"0","summary":"Salarius Pharmaceuticals Shares Fall 11.7% as FDA Puts Cancer Drug Trial on Partial Clinical Hold","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240711:nFWN3J30NZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SLRX"],"gpt_icon":0},{"id":"2450526773","title":"BUZZ-Salarius Pharma falls as FDA puts cancer drug trial on partial clinical hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2450526773","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450526773?lang=en_us&edition=fundamental","pubTime":"2024-07-11 20:52","pubTimestamp":1720702349,"startTime":"0","endTime":"0","summary":"** Shares of drug developer Salarius Pharmaceuticals  fall 20.8% to $2.17 premarket   ** Co says FDA has placed a partial clinical hold on its early-stage trial studying its experimental drug seclidemstat in combination with chemotherapy drug azacitidine in adult patients with type of blood cancer   ** No new patients may be enrolled at this time; currently enrolled patients may continue treatment and all study procedures if they are benefiting        ** On July 9, researchers at The University of Texas MD Anderson Cancer Center  notified co that a patient experienced unexpected serious adverse event - filing   ** Co intends to support researchers at MDACC to analyze the available data and respond to questions submitted by the FDA   ** Up to last close, stock down 47.26% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SLRX","BUZZ"],"gpt_icon":0},{"id":"2450354991","title":"Salarius Pharmaceuticals Shares Down 21.6% Premarket as FDA Puts Cancer Drug Trial on Partial Clinical Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2450354991","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2450354991?lang=en_us&edition=fundamental","pubTime":"2024-07-11 20:40","pubTimestamp":1720701654,"startTime":"0","endTime":"0","summary":"Salarius Pharmaceuticals Shares Down 21.6% Premarket as FDA Puts Cancer Drug Trial on Partial Clinical Hold","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240711:nFWN3J30QF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SLRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.salariuspharma.com","stockEarnings":[{"period":"1week","weight":0.0224},{"period":"1month","weight":-0.2346},{"period":"3month","weight":-0.2634},{"period":"6month","weight":-0.646},{"period":"1year","weight":-0.7314},{"period":"ytd","weight":-0.7365}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. The company is headquartered in Houston, Texas.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.005639},{"month":2,"riseRate":0.4,"avgChangeRate":-0.000908},{"month":3,"riseRate":0.5,"avgChangeRate":0.031094},{"month":4,"riseRate":0.2,"avgChangeRate":-0.075189},{"month":5,"riseRate":0.5,"avgChangeRate":-0.013003},{"month":6,"riseRate":0.5,"avgChangeRate":-0.069204},{"month":7,"riseRate":0.3,"avgChangeRate":-0.116732},{"month":8,"riseRate":0.3,"avgChangeRate":-0.087267},{"month":9,"riseRate":0.1,"avgChangeRate":-0.102733},{"month":10,"riseRate":0.3,"avgChangeRate":-0.147148},{"month":11,"riseRate":0.4,"avgChangeRate":0.00366},{"month":12,"riseRate":0.222222,"avgChangeRate":-0.085424}],"exchange":"NASDAQ","name":"Salarius Pharmaceuticals Inc","nameEN":"Salarius Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Salarius Pharmaceuticals Inc(SLRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Salarius Pharmaceuticals Inc(SLRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Salarius Pharmaceuticals Inc,SLRX,Salarius Pharmaceuticals Inc股票,Salarius Pharmaceuticals Inc股票老虎,Salarius Pharmaceuticals Inc股票老虎国际,Salarius Pharmaceuticals Inc行情,Salarius Pharmaceuticals Inc股票行情,Salarius Pharmaceuticals Inc股价,Salarius Pharmaceuticals Inc股市,Salarius Pharmaceuticals Inc股票价格,Salarius Pharmaceuticals Inc股票交易,Salarius Pharmaceuticals Inc股票购买,Salarius Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Salarius Pharmaceuticals Inc(SLRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Salarius Pharmaceuticals Inc(SLRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction